14-64801382-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001355436.2(SPTB):c.666T>C(p.Phe222Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00853 in 1,614,164 control chromosomes in the GnomAD database, including 313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.019 ( 74 hom., cov: 33)
Exomes 𝑓: 0.0074 ( 239 hom. )
Consequence
SPTB
NM_001355436.2 synonymous
NM_001355436.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.374
Publications
4 publications found
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
- hereditary spherocytosis type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- elliptocytosis 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary elliptocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary spherocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 14-64801382-A-G is Benign according to our data. Variant chr14-64801382-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.374 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0599 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPTB | NM_001355436.2 | c.666T>C | p.Phe222Phe | synonymous_variant | Exon 7 of 36 | ENST00000644917.1 | NP_001342365.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPTB | ENST00000644917.1 | c.666T>C | p.Phe222Phe | synonymous_variant | Exon 7 of 36 | NM_001355436.2 | ENSP00000495909.1 | |||
| SPTB | ENST00000389722.7 | c.666T>C | p.Phe222Phe | synonymous_variant | Exon 6 of 35 | 2 | ENSP00000374372.3 | |||
| SPTB | ENST00000389720.4 | c.666T>C | p.Phe222Phe | synonymous_variant | Exon 7 of 32 | 5 | ENSP00000374370.4 |
Frequencies
GnomAD3 genomes AF: 0.0192 AC: 2925AN: 152230Hom.: 74 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2925
AN:
152230
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0185 AC: 4653AN: 251442 AF XY: 0.0165 show subpopulations
GnomAD2 exomes
AF:
AC:
4653
AN:
251442
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00742 AC: 10843AN: 1461816Hom.: 239 Cov.: 32 AF XY: 0.00758 AC XY: 5511AN XY: 727204 show subpopulations
GnomAD4 exome
AF:
AC:
10843
AN:
1461816
Hom.:
Cov.:
32
AF XY:
AC XY:
5511
AN XY:
727204
show subpopulations
African (AFR)
AF:
AC:
1511
AN:
33472
American (AMR)
AF:
AC:
2767
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
705
AN:
26134
East Asian (EAS)
AF:
AC:
1387
AN:
39696
South Asian (SAS)
AF:
AC:
2237
AN:
86252
European-Finnish (FIN)
AF:
AC:
47
AN:
53400
Middle Eastern (MID)
AF:
AC:
27
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1528
AN:
1111978
Other (OTH)
AF:
AC:
634
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
695
1390
2085
2780
3475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0192 AC: 2930AN: 152348Hom.: 74 Cov.: 33 AF XY: 0.0192 AC XY: 1431AN XY: 74508 show subpopulations
GnomAD4 genome
AF:
AC:
2930
AN:
152348
Hom.:
Cov.:
33
AF XY:
AC XY:
1431
AN XY:
74508
show subpopulations
African (AFR)
AF:
AC:
1785
AN:
41574
American (AMR)
AF:
AC:
612
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
73
AN:
3472
East Asian (EAS)
AF:
AC:
169
AN:
5180
South Asian (SAS)
AF:
AC:
114
AN:
4832
European-Finnish (FIN)
AF:
AC:
6
AN:
10628
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
122
AN:
68034
Other (OTH)
AF:
AC:
47
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
152
305
457
610
762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
124
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Nov 14, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.